Why the immune system fails to kill HIV

July 18, 2014
hiv
Scanning electron micrograph of an HIV-infected H9 T cell. Credit: NIAID

Our immune system contains CD8+ T cells which protect us from various diseases such as cancer and viruses. Some of them are specifically tasked with killing cells infected with the HIV virus – and researchers from Karolinska Institutet in Sweden, together with international colleagues, have for the first time identified a key explanation for why these cells are unsuccessful in their task. In simple terms, the immune system's ignition keys have not been turned all the way to the start position, which would enable the CD8+ T cells to kill the cells infected with HIV.

It has long been known that CD8+ T that are meant to target and kill the HIV virus lose important functions; they become exhausted and cannot complete their task. In one study, published in the journal PLOS Pathogens, researchers have successfully shown at the molecular level what it is that weakens these important CD8+ T cells.

There are two that are particularly important to CD8+ T cells. They are called T-bet and Eomes and work as ignition keys for the machinery of the immune system – they ensure that CD8+ T cells are correctly instructed to fight the specific disease. In simple terms, T-bet has the role of an instigator that induces CD8+ T cells to divide and mature. Eomes have a more regulatory role and are primarily active in building a memory against an infection that has completely healed, in order to be ready for a new episode of the infection.

Researchers have studied how T-bet and Eomes are expressed in a total of 64 HIV-infected people, the majority of whom were treated in the infection clinic at the Karolinska University Hospital and the sexual health clinic at the Stockholm South General Hospital. The study shows that the CD8+ T cells specifically targeting HIV-infected cells have a low expression of T-bet, but an increased expression of regulatory Eomes. This leads to CD8+ T cells that are maturing poorly and inhibit their ability to kill HIV-infected cells.

Unfortunately, this pattern of the transcription factors was present even when the participants' HIV was responding well to medication, in that the level of HIV virus sunk so low that it was not measurable in their blood.

"This probably explains why CD8+ T cells continue to function poorly despite long-term treatment with antiviral drugs. We have previously known this to be the case, though we have not known why", says Marcus Buggert, researcher at the Department of Laboratory Medicine at Karolinska Institutet.

The researchers hope to discover how the transcription factors' expression can be affected so that T-bet can be increased in patients with HIV. That would possibly give the a chance of killing HIV-infected cells and thus making it easier to cure HIV infection.

"If we can get past this barrier and discover how to control the regulation of these transcription factors, this would open the door to creating a vaccine or cure for HIV. This could be one way of creating an effective immune response that is able to kill HIV-infected cells", says Annika Karlsson, senior research fellow in virology at the Department of Laboratory Medicine at Karolinska Institutet.

Explore further: Hemophilia and long-term HIV infection—is there a protective link?

More information: "T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection." Marcus Buggert, Johanna Tauriainen, Takuya Yamamoto, Juliet Frederiksen, Martin A. Ivarsson, Jakob Michaëlsson, Ole Lund, Bo Hejdeman, Marianne Jansson, Anders Sönnerborg, Richard A. Koup, Michael R. Betts, Annika C. Karlsson. PLOS Pathogens, online 17 July 2014, dx.plos.org/10.1371/journal.ppat.1004251

Related Stories

Hemophilia and long-term HIV infection—is there a protective link?

December 11, 2013
People with the genetic blood clotting disorder hemophilia who have been infected with HIV for decades have an increased proportion of immune cells in their blood that specifically target HIV. This protective immune response ...

New monkey model for AIDS offers promise for medical research

June 19, 2014
HIV-1, the virus responsible for most cases of AIDS, is a very selective virus. It does not readily infect species other than its usual hosts – humans and chimpanzees. While this would qualify as good news for most mammals, ...

Scientists uncover features of antibody-producing cells in people infected with HIV

June 3, 2014
By analyzing the blood of almost 100 treated and untreated HIV-infected volunteers, a team of scientists has identified previously unknown characteristics of B cells in the context of HIV infection. B cells are the immune ...

Recommended for you

Scientists divulge latest in HIV prevention

July 25, 2017
A far cry from the 1990s "ABC" campaign promoting abstinence and monogamy as HIV protection, scientists reported on new approaches Tuesday allowing people to have all the safe sex they want.

Girl's HIV infection seems under control without AIDS drugs

July 24, 2017
A South African girl born with the AIDS virus has kept her infection suppressed for more than eight years after stopping anti-HIV medicines—more evidence that early treatment can occasionally cause a long remission that, ...

Meds by monthly injection might revolutionize HIV care (Update)

July 24, 2017
Getting a shot of medication to control HIV every month or two instead of having to take pills every day could transform the way the virus is kept at bay.

Candidate AIDS vaccine passes early test

July 24, 2017
The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Paris spotlight on latest in AIDS science

July 21, 2017
Some 6,000 HIV experts gather in Paris from Sunday to report advances in AIDS science as fading hopes of finding a cure push research into new fields.

Scientists elicit broadly neutralizing antibodies to HIV in calves

July 20, 2017
Scientists supported by the National Institutes of Health have achieved a significant step forward, eliciting broadly neutralizing antibodies (bNAbs) to HIV by immunizing calves. The findings offer insights for HIV vaccine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.